MONASH IVF GROUP LIMITED — Director's Dealing 2025

Jun 23, 2025

==> picture [596 x 118] intentionally omitted <==

ASX Announcement

Monash IVF Group Limited (ASX:MVF)

24 June 2025

Appendix 3Z – Late Lodgement Notice

Monash IVF Group Limited (ASX: MVF, the "Company") attaches an Appendix 3Z for Mr Michael Knaap, who resigned as Chief Executive Officer and Managing Director of the Company effective 12 June 2025.

Disclosure of Mr Knaap's resignation was provided to the market at the appropriate time. However, the required Appendix 3Z was inadvertently not lodged.

The Company considers that it has in place the necessary education, reporting, and notification policies to ensure compliance with the disclosure obligations under Listing Rules 3.19A and 3.19B. The directors are aware of their responsibilities under Listing Rules 3.19A and 3.19B and are conscious of lodgements being made in a timely manner.

The Company considers its current policies and procedures to be adequate; however, it will take further precautions to prevent a similar incident from occurring again.

Approved by the Chairman

ENDS

For further information please contact:

Malik Jainudeen

Chief Financial Officer & Company Secretary and Acting CEO Monash IVF Group Limited T: +61 3 9420 8235

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Monash IVF Group Limited

ABN 90 169 302 309

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Michael Damian Knaap
Date of last notice	4 December 2024
Date that director ceased to be director	12 June 2025

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

734,642 ordinary shares

Performance Rights:

• 532,599 under the 2023 Equity Incentive Plan

• 517,433 under the 2024 Equity Incentive Plan

• 552,782 under the 2025 Equity Incentive Plan

• 61,665 as a deferral of 20% of Mr Knaap’s short term incentive for FY2024

• See chapter 19 for defined terms.

Appendix 3Z Page 1

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

	Name of holder & nature of interestNote: Provide details of the circumstances givingrise to the relevant interestIndirect interest of OrdinaryShares held by MKN FamilyHoldings Pty Ltd as trustee forthe Pakhill Superannuation Fund	Name of holder & nature of interestNote: Provide details of the circumstances givingrise to the relevant interestIndirect interest of OrdinaryShares held by MKN FamilyHoldings Pty Ltd as trustee forthe Pakhill Superannuation Fund	Number & class of securities150,655 Ordinary Shares	Number & class of securities150,655 Ordinary Shares

Part 3 – Director’s interests in contracts

Detail of contract	n/a
Nature of interest	n/a
Name of registered holder(if issued securities)	n/a
No. and class of securities to whichinterest relates	n/a

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002